In vitro CYP inhibition, time-dependent inhibition, induction, and P-gp/BCRP interaction studies to assess drug–drug interaction risk and support ADME evaluation in preclinical development.
In vitro CYP inhibition, time-dependent inhibition, induction, and P-gp/BCRP interaction studies to assess drug–drug interaction risk and support ADME evaluation in preclinical development.